Fig. 7From: Nonviral delivery systems for antisense oligonucleotide therapeuticsBiomimetic carriers for ASO delivery. AÂ Components from a variety of cells and body fluids have been used to prepare biomimetic nanoparticles. BÂ Cells can be forced to pass through membrane pores to form biomimetic nanoparticles. CÂ Sulfhydryl-blocking can lead to the release of small biomimetic nanoparticles from the cell; UV light can induce apoptosis and produce small apoptotic bodies. DÂ Isolated natural EVs and liposome nanoparticles can be fused into hybrid EVsBack to article page